Haier Biomedical at ISBT Congress 2026
Analysis based on 8 articles · First reported Jul 21, 2026 · Last updated Jul 28, 2026
The event is a routine product showcase with limited direct market impact. It reinforces Haier Biomedical's position in the blood management market but is unlikely to materially affect its stock price.
Haier Biomedical (SHA: 688139) participated at the ISBT Congress 2026 in Kuala Lumpur, Malaysia, on July 21, 2026, presenting its blood product portfolio and integrated workflow solutions to the global transfusion market. The company unveiled an integrated blood management solution covering the entire workflow from blood collection to clinical application, and highlighted core equipment including the EU MDR-certified Plasma Apheresis System and Automated Blood Management Refrigerator. Automation Solution Specialist Daniele Pericolini presented the deployment of Haier Biomedical's R-Series Automated Blood Management Refrigerator at the New Arcispedale Sant Anna Hospital in Ferrara, Italy, where the hospital transitioned from paper records to RFID-enabled digital tracking. Blood Chain Product Manager Zhou Weidong presented deployments at Brazil's HemoRio Blood Bank and the Philippines' Asia Pacific Medical Center. Haier Biomedical's digital blood management solution, built on AI, automation, and IoT architecture, enables real-time monitoring and full traceability. The company's U-Blood lot solutions are already operational in Germany, Italy, Thailand, the Philippines, Morocco, Brazil, Zambia, and Kenya.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard